Storage and monitoring of ManNac for FDA regulations
Open Pre-Solicitation Posted
- Solicitation number
- 75N98027Q00086
- Agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Bethesda, Maryland 20892, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institutes of Health (NIH) intends to negotiate and award a non-competitive contract to Eminent Services Corp of Frederick, Maryland, for storage and monitoring of ManNac for FDA regulations, with responses due November 26, 2026. The action is a sole-source notice of intent under FAR Subpart 13.106-1(b)(1), which permits soliciting from a single source under simplified acquisition procedures, and it is not expected to exceed the $350,000 simplified acquisition threshold. No set-aside is used. The contracting office is the NIH Office of Acquisition and Logistics Management, Hospital and Laboratory Support Division, 6701 Rockledge Drive, Bethesda, Maryland 20817. The resultant contract will incorporate clauses in effect through FAC 2026-01, dated March 13, 2026. The procurement carries NAICS 541380 with a $19,000,000 size standard and PSC 6505 (Drugs and Biologicals). The notice is Presolicitation Synopsis 75N98027Q00086, posted November 16, 2026.
Notice text
General Information
Document Type:
Presolicitation
Synopsis Number:
75N98027Q00086
Posted Date:
November 16, 2026
Original Response Date:
November 26, 2026
Current Response Date:
November 26, 2026
Set Aside:
N/A
NAICS Code:
541380
Contracting Office Address
National Institutes of Health (NIH), Office of the Director (OD)
Office of Logistics and Operations (OLAO)
Office of Acquisition and Logistics Management (OALM)
Hospital and Laboratory Support Division
6701 Rockledge Drive
Bethesda, MD 20817
Description
INTRODUCTION
THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME).
The National Institutes of Health (NIH) intends to negotiate and award a contract without providing for full and open competition (Including brand-name) to:
Eminent Services Corp
7495 New Technology WAY
Frederick, Maryland
21703
NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE
The intended procurement is classified under NAICS code 541380 with a Size Standard $19,000,000.
REGULATORY AUTHORITY
The resultant contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 2026-01, March 13, 2026. This acquisition is conducted under the procedures as prescribed in FAR subpart 13-Simplified Acquisition Procedures at an amount not exceeding the simplified acquisition threshold ($350,000).
STATUTORY AUTHORITY
This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures, Subpart 13.106-1 (b) (1), Soliciting from a single source and is not expected to exceed the simplified acquisition threshold. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.
GENERAL INFORMATION
- Title: Storage and monitoring of ManNac for FDA regulations
- Background Information: Under this task order, the contractor will independently provide support services to satisfy the overall operational objectives of the National Human Genome Research Institute (NHGRI). The refrigerated storage of the clinical grade drug-in-sachet needs to be conducted under strict temperature control and FDA-regulatory requirements.
NHGRI wants to contract a company for long-term refrigerated storage of a large batch of our unlabeled investigational drug N-acetylmannosamine (ManNAc), the drug is packaged as powder-in-sachets and stored in 16 boxes (8x12x14’’box dimensions) and contain 600 sachets/box. NHGRI plans to use this drug in future clinical trials of ManNAc for other indications, such as GNE-related thrombocytopenia or nephrotic disease. NHGRI anticipates storing this batch of unlabeled drug at a company for a period of up to 2 years. The refrigerated storage of the clinical grade drug-in-sachet needs to be conducted under strict temperature control and FDA-regulatory requirements.
CLOSING STATEMENT
This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include a technical proposal, a cost-price proposal, the period of performance, the Unique Entity ID (UEI), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.
A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement.
All responses must be received by November 26, 2026 at 9:00 AM Eastern time and must reference solicitation number 75N98027Q00086. Responses may be submitted electronically to Mr. James Law, Contracting Officer at James.Law@nih.gov. Fax responses will not be accepted.
"All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency.”
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity